π¬ TZP resistance not linked to higher death risk in blood infections
A Danish cohort study investigated whether piperacillin-tazobactam resistant blood infections increase mortality risk. Researchers analyzed 34,379 patients with E coli or K pneumoniae BSIs from November 2018 to November 2024. Crude mortality was higher for resistant infections initially, but this difference vanished after adjusting for risk factors. The study concludes that TZP resistance does not equate to a higher mortality risk in this Danish cohort. This finding is relevant given rising resistance concerns in Denmark. π§